BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10734671)

  • 1. [Prognostic factors in endometrial carcinoma].
    Ivanov S; Ivanov S
    Akush Ginekol (Sofiia); 1999; 38(3):16-8. PubMed ID: 10734671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
    Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
    J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic factors of stage III endometrial carcinoma].
    Li J; Kong WM
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):198-200. PubMed ID: 19537039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New concepts in the diagnosis and prognosis of endometrial carcinoma.
    Sasano H; Watanabe K; Ito K; Sato S; Yajima A
    Pathol Annu; 1994; 29 ( Pt 2)():31-49. PubMed ID: 7936750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial carcinoma.
    Rose PG
    N Engl J Med; 1996 Aug; 335(9):640-9. PubMed ID: 8692240
    [No Abstract]   [Full Text] [Related]  

  • 6. May cathepsin D immunoreactivity be used as a prognostic factor in endometrial carcinomas? A comparative immunohistochemical study.
    Saygili U; Koyuncuoglu M; Altunyurt S; Guclu S; Uslu T; Erten O
    Gynecol Oncol; 2001 Oct; 83(1):20-4. PubMed ID: 11585409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognostic factors in endometrial carcinoma (EC)].
    Gorchev G
    Akush Ginekol (Sofiia); 1995; 34(2):51-3. PubMed ID: 8651426
    [No Abstract]   [Full Text] [Related]  

  • 8. Is endometrial carcinoma intrinsically more aggressive in elderly patients?
    Alektiar KM; Venkatraman E; Abu-Rustum N; Barakat RR
    Cancer; 2003 Dec; 98(11):2368-77. PubMed ID: 14635071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of abnormal uterine bleeding and the pathology of endometrial hyperplasia.
    Espindola D; Kennedy KA; Fischer EG
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):717-37, ix. PubMed ID: 18061866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal cytology in endometrial cancer.
    Mlyncek M; Uharcek P
    Neoplasma; 2005; 52(2):103-8. PubMed ID: 15800707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
    Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of endometrial adenocarcinoma.
    Barwick TD; Rockall AG; Barton DP; Sohaib SA
    Clin Radiol; 2006 Jul; 61(7):545-55. PubMed ID: 16784939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-3-3sigma in endometrial cancer--a possible prognostic marker in early-stage cancer.
    Ito K; Suzuki T; Akahira J; Sakuma M; Saitou S; Okamoto S; Niikura H; Okamura K; Yaegashi N; Sasano H; Inoue S
    Clin Cancer Res; 2005 Oct; 11(20):7384-91. PubMed ID: 16243811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial cancer.
    Sorosky JI
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):436-47. PubMed ID: 18238985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMP-2 expression associates with CA 125 and clinical course in endometrial carcinoma.
    Honkavuori M; Talvensaari-Mattila A; Soini Y; Turpeenniemi-Hujanen T; Santala M
    Gynecol Oncol; 2007 Jan; 104(1):217-21. PubMed ID: 16996112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endometrial carcinoma in patients with diabetes mellitus].
    Steiner E; Eicher O; Hofmann M; Weikel W; Schmidt M; Pilch H; Knapstein PG
    Zentralbl Gynakol; 2001 Nov; 123(11):622-5. PubMed ID: 11797159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.
    Creutzberg CL; van Putten WL; Wárlám-Rodenhuis CC; van den Bergh AC; de Winter KA; Koper PC; Lybeert ML; Slot A; Lutgens LC; Stenfert Kroese MC; Beerman H; van Lent M;
    J Clin Oncol; 2004 Apr; 22(7):1234-41. PubMed ID: 15051771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.